Showing results (1171-1180 of 1,767) with videos related to

Sort By:
Pageof 177
JAMA Neurology|December 6, 2021
Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by StereoelectroencephalographyAlexandra Astner-Rohracher, Georg Zimmermann, Tamir Avigdor, et al.
JAMA Neurology|November 22, 2021
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesMaria C Gonzalez, Nicholas J Ashton, Bárbara Fernandes Gomes, et al.
JAMA Neurology|October 31, 2022
Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older AdultsAlifiya Kapasi, Julie A Schneider, Lei Yu, et al.
JAMA Neurology|October 31, 2022
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical PracticeDianalee McKnight, Ana Morales, Kathryn E Hatchell, et al.
JAMA Neurology|October 17, 2022
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical TrialMichael J Pontecorvo, Ming Lu, Samantha C Burnham, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
JAMA Neurology|October 24, 2022
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol ProjectJennifer J Manly, Richard N Jones, Kenneth M Langa, et al.
JAMA Neurology|September 6, 2022
Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UKBorja Del Pozo Cruz, Matthew Ahmadi, Sharon L Naismith, et al.
JAMA Neurology|September 6, 2022
Association Between Traumatic Brain Injury and Subsequent Cardiovascular Disease Among Post-9/11-Era VeteransIan J Stewart, Megan E Amuan, Chen-Pin Wang, et al.
JAMA Neurology|September 12, 2022
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical TrialSergey Shcherbinin, Cynthia D Evans, Ming Lu, et al.
Pageof 177